PL2768312T3 - Kompozycja do stosowania dla wspomagania zdrowego rozwoju oraz/albo w zapobieganiu oraz/albo w leczeniu chorób kości - Google Patents

Kompozycja do stosowania dla wspomagania zdrowego rozwoju oraz/albo w zapobieganiu oraz/albo w leczeniu chorób kości

Info

Publication number
PL2768312T3
PL2768312T3 PL12770507T PL12770507T PL2768312T3 PL 2768312 T3 PL2768312 T3 PL 2768312T3 PL 12770507 T PL12770507 T PL 12770507T PL 12770507 T PL12770507 T PL 12770507T PL 2768312 T3 PL2768312 T3 PL 2768312T3
Authority
PL
Poland
Prior art keywords
promotion
prevention
treatment
composition
bone
Prior art date
Application number
PL12770507T
Other languages
English (en)
Inventor
Degonda Gabriela Bergonzelli
Gutierrez Euridice Castaneda
Clara Garcia-Rodenas
Cavin Elizabeth Offord
Stéphanie Viguet-Carrin
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47010620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2768312(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of PL2768312T3 publication Critical patent/PL2768312T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PL12770507T 2011-10-18 2012-10-15 Kompozycja do stosowania dla wspomagania zdrowego rozwoju oraz/albo w zapobieganiu oraz/albo w leczeniu chorób kości PL2768312T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11185608 2011-10-18
PCT/EP2012/070370 WO2013057063A1 (en) 2011-10-18 2012-10-15 Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
EP12770507.7A EP2768312B1 (en) 2011-10-18 2012-10-15 Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease

Publications (1)

Publication Number Publication Date
PL2768312T3 true PL2768312T3 (pl) 2016-06-30

Family

ID=47010620

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12770507T PL2768312T3 (pl) 2011-10-18 2012-10-15 Kompozycja do stosowania dla wspomagania zdrowego rozwoju oraz/albo w zapobieganiu oraz/albo w leczeniu chorób kości

Country Status (14)

Country Link
US (1) US9662358B2 (pl)
EP (1) EP2768312B1 (pl)
CN (1) CN103889241B (pl)
AU (1) AU2012324986B2 (pl)
BR (1) BR112014009097A2 (pl)
CL (1) CL2014000833A1 (pl)
ES (1) ES2559381T3 (pl)
MX (1) MX2014004722A (pl)
PH (1) PH12014500558A1 (pl)
PL (1) PL2768312T3 (pl)
PT (1) PT2768312E (pl)
RU (1) RU2014119930A (pl)
WO (1) WO2013057063A1 (pl)
ZA (1) ZA201403596B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3020949B1 (fr) * 2014-05-16 2018-02-09 Ecole Normale Superieure De Lyon Composition permettant de favoriser la croissance juvenile humaine et animale en cas de malnutrition
CN104397359B (zh) * 2014-12-10 2017-08-25 陕西博森生物制药股份集团有限公司 一种氨基酸螯合钙组合物及其制备方法
FR3047640B1 (fr) 2016-02-12 2025-08-29 Ecole Normale Superieure Lyon Composition probiotique permettant de favoriser la croissance juvenile de l'animal d'elevage
CN106858605A (zh) * 2016-12-26 2017-06-20 吉林舒润生物科技有限公司 一种用于预防及治疗骨吸收相关疾病的益生菌钙功能食品
CN113143973A (zh) * 2017-03-07 2021-07-23 景岳生物科技股份有限公司 抗骨质流失的副干酪乳杆菌菌株gmnl-653的组合物
CN107439598A (zh) * 2017-05-14 2017-12-08 烟台丰成农业科技有限公司 抗茄子青枯病复合微生物菌剂的生产工艺
CA3078317A1 (en) * 2017-11-08 2019-05-16 Societe Des Produits Nestle S.A. Bioconversion of oleuropein
CN110964656B (zh) * 2018-09-30 2021-05-28 内蒙古伊利实业集团股份有限公司 一种可预防骨质疏松的乳双歧杆菌bl-99及其应用
WO2020063553A1 (zh) 2018-09-30 2020-04-02 内蒙古伊利实业集团股份有限公司 一种乳双歧杆菌bl-99及其应用
EP3656760A1 (de) 2018-11-21 2020-05-27 Evonik Operations GmbH Lagerstabile form von 3-methylthiopropionaldehyd
EP3972429A1 (en) * 2019-05-21 2022-03-30 Société des Produits Nestlé S.A. Dietary butyrate and its uses
MX2022010647A (es) * 2020-02-27 2022-09-23 Abbott Lab Metodos para mejorar la salud osea.
CN115666585A (zh) * 2020-05-22 2023-01-31 雀巢产品有限公司 人乳低聚糖在营养组合物中用于增强骨发育和/或骨强度的用途
CN112760247B (zh) * 2020-11-10 2022-10-25 深圳华大生命科学研究院 用于预防和/或治疗生殖道菌群紊乱和/或骨质流失引起的疾病的鼠李糖乳杆菌
CN116369527B (zh) * 2023-03-09 2024-07-30 江南大学 一株可调节骨骼发育的短双歧杆菌及其应用
CN117887617A (zh) * 2023-12-01 2024-04-16 君乐宝乳业集团股份有限公司 一种促进骨骼健康的组合物及应用
CN119791282B (zh) * 2024-05-27 2025-11-28 合生元（广州）健康产品有限公司 提高骨骼密度的组合物及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180674A (en) 1990-04-16 1993-01-19 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
AU2745700A (en) * 1999-02-01 2000-08-18 Dermal Research Laboratories, Inc. A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US7435431B2 (en) 2004-07-28 2008-10-14 Abbott Laboratories Method for controlling body weight in estrogen-insufficient women
CN101005849A (zh) * 2004-07-28 2007-07-25 艾博特公司 治疗或预防骨质疏松症的营养组合物和方法
EP1871795A4 (en) * 2005-04-08 2010-03-31 Biogenerix Ag COMPOSITIONS AND METHOD FOR PRODUCING GLYCOSYLATION MUTANTS OF A PROTEASE-RESISTANT HUMAN GROWTH HORMONE
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
RU2430631C2 (ru) 2006-02-10 2011-10-10 Нестек С.А. Пребиотическая смесь олигосахаридов и пищевой продукт, ее содержащий
EP1993576B1 (en) 2006-03-07 2015-10-21 Nestec S.A. Synbiotic mixture
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
US20090118229A1 (en) 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
CN102595934A (zh) 2009-11-12 2012-07-18 雀巢产品技术援助有限公司 用于促进肠微生物群平衡和健康的营养组合物
CN103596440A (zh) * 2011-06-08 2014-02-19 雀巢产品技术援助有限公司 含有外源性乳脂肪球膜组分的营养组合物

Also Published As

Publication number Publication date
PH12014500558A1 (en) 2014-04-14
RU2014119930A (ru) 2015-11-27
PT2768312E (pt) 2016-02-23
BR112014009097A2 (pt) 2017-04-18
US20140248247A1 (en) 2014-09-04
US9662358B2 (en) 2017-05-30
ZA201403596B (en) 2016-01-27
EP2768312B1 (en) 2015-12-09
EP2768312A1 (en) 2014-08-27
ES2559381T3 (es) 2016-02-11
AU2012324986A1 (en) 2014-03-27
MX2014004722A (es) 2015-02-05
CN103889241A (zh) 2014-06-25
AU2012324986A2 (en) 2014-05-15
CL2014000833A1 (es) 2014-08-22
WO2013057063A1 (en) 2013-04-25
CN103889241B (zh) 2016-08-17
AU2012324986B2 (en) 2015-12-03

Similar Documents

Publication Publication Date Title
ZA201403596B (en) Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
PH12013500892A1 (en) Composition for use in the prevention and/or treatment of skin conditions and skin diseases
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
PL2771041T3 (pl) Kompozycje i ich zastosowanie w gojeniu się kości
IL231510B (en) Preparations for the treatment of bone diseases and broken bones
EP2621588A4 (en) METHODS AND COMPOSITIONS FOR TREATING DISEASE USING INHALATION
IL223241A0 (en) Cysteamine derivatives and their use in the treatment of nash
IL221874A (en) History of pyrimidine and their use in the treatment of respiratory diseases such as copd
GB2548034B (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
ZA201303810B (en) Methods and compositions suitable for promoting healthy skin
GB2497899B (en) Sanguiin for use in the prevention or treatment of bone marrow inhibition
PT2621520E (pt) Composições de colagenase g e colagenase h para o tratamento de doenças que envolvem alterações de colagénio
PT2407151T (pt) Composição para o tratamento de lesões da pele e/ou unhas
GB2470818B (en) Methods for administration and formulations for the treatment of regional adipose tissue
GB2496800B (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
IL225793A0 (en) Methods and preparations for curing insulin-related medical conditions
EP2709632A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF SKIN DISEASES
IL223095A0 (en) Methods and compositions for treatment nf-kb-mediated and a7 integrin-suppressed diseases
ZA201401800B (en) Novel plant defensins and use in the treatment of proliferative diseases
IL222482A0 (en) Methods and compositions for the treatment of fluid accumulation in and/or under the retina
GB201114289D0 (en) Flurbiprofen and related compounds for the treatment of skin diseases
IL216717A0 (en) USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES
HUE038120T2 (hu) Transzferrin autoimmun betegségek kezelésében és/vagy megelõzésében történõ alkalmazásra
PT2537528E (pt) As composições farmacêuticas contendo beta- e alfagalactosidase e a sua utilização no tratamento da doença do refluxo gastro esofágico
IL243237A0 (en) Methods and preparations for the treatment of fluid accumulation in and/or under the retina